Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Humana backs 2020 group Medicare Advantage membership growth outlook » 06:48
08/05/20
08/05
06:48
08/05/20
06:48
HUM

Humana

$391.19 /

-3.69 (-0.93%)

The company is…

The company is reiterating its expectations for group Medicare Advantage net membership gains for FY 2020, projecting an increase of approximately 90,000 members year over year. For its stand-alone PDP business, Humana continues to estimate a net membership decline of approximately 550,000 members for FY 2020.

ShowHide Related Items >><<
HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

07/27/20 BofA
Accolade initiated with a Buy at BofA
07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
07/01/20 SVB Leerink
Humana reinstated with an Outperform at SVB Leerink
HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

Earnings
Humana backs FY20 adjusted EPS view $18.25-$18.75, consensus $18.72 » 06:31
08/05/20
08/05
06:31
08/05/20
06:31
HUM

Humana

$391.19 /

-3.69 (-0.93%)

Reaffirms FY 2020…

Reaffirms FY 2020 adjusted EPS guidance range of $18.25 to $18.75 while acknowledging the inherent uncertainty surrounding the ongoing pandemic. Increases full year expected individual Medicare Advantage membership growth to 330,000 to 360,000 members from previous range of 300,000 to 350,000 members.

ShowHide Related Items >><<
HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

07/27/20 BofA
Accolade initiated with a Buy at BofA
07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
07/01/20 SVB Leerink
Humana reinstated with an Outperform at SVB Leerink
HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

Earnings
Humana reports Q2 adjusted EPS $12.56, consensus $10.27 » 06:30
08/05/20
08/05
06:30
08/05/20
06:30
HUM

Humana

$391.19 /

-3.69 (-0.93%)

Reports Q2 revenue…

Reports Q2 revenue $19.08B, consensus $18.63B.

ShowHide Related Items >><<
HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

07/27/20 BofA
Accolade initiated with a Buy at BofA
07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
07/01/20 SVB Leerink
Humana reinstated with an Outperform at SVB Leerink
HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

Conference/Events
IBM to hold a virtual conference » 04:55
08/05/20
08/05
04:55
08/05/20
04:55
IBM

IBM

$125.86 /

+1.57 (+1.26%)

IBM Integration Technical…

IBM Integration Technical Virtual Conference 2020 will be held on August 4-6. Webcast Link

ShowHide Related Items >><<
IBM IBM
$125.86 /

+1.57 (+1.26%)

IBM IBM
$125.86 /

+1.57 (+1.26%)

07/22/20 Argus
IBM upgraded to Buy from Hold at Argus
07/22/20 Argus
IBM upgraded to Buy from Hold at Argus
07/21/20 Wells Fargo
IBM price target raised to $130 from $120 at Wells Fargo
07/21/20 Morgan Stanley
IBM price target raised to $128 from $111 at Morgan Stanley
IBM IBM
$125.86 /

+1.57 (+1.26%)

IBM IBM
$125.86 /

+1.57 (+1.26%)

IBM IBM
$125.86 /

+1.57 (+1.26%)

IBM IBM
$125.86 /

+1.57 (+1.26%)

Yesterday
Earnings
Notable companies reporting before tomorrow's open » 14:17
08/04/20
08/04
14:17
08/04/20
14:17
CVX

Chevron

$86.07 /

+1.255 (+1.48%)

, REGN

Regeneron

$641.43 /

-3.9 (-0.60%)

, HUM

Humana

$391.52 /

-3.36 (-0.85%)

, SRE

Sempra Energy

$124.11 /

+0.05 (+0.04%)

, TRI

Thomson Reuters

$70.45 /

+0.09 (+0.13%)

, MRNA

Moderna

$77.69 /

-0.29 (-0.37%)

, W

Wayfair

$280.50 /

-7.09 (-2.47%)

, ABC

AmerisourceBergen

$104.65 /

+0.15 (+0.14%)

, EVRG

Evergy

$56.21 /

-6.52 (-10.39%)

, TEVA

Teva

$12.07 /

-0.12 (-0.98%)

, HZNP

Horizon Therapeutics

$61.40 /

-1.68 (-2.66%)

, CRL

Charles River

$204.19 /

-3.28 (-1.58%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include CVS Health (CVS), consensus $1.93... Regeneron (REGN), consensus $5.59... Humana (HUM), consensus $10.34... Sempra Energy (SRE), consensus $1.66... Thomson Reuters (TRI), consensus 39c... Moderna (MRNA), consensus (36c)... Wayfair (W), consensus 53c... AmerisourceBergen (ABC), consensus $1.55... Evergy (EVRG), consensus 70c... Teva (TEVA), consensus 50c... Horizon Therapeutics (HZNP), consensus 40c... Charles River Laboratories (CRL), consensus $1.27.

ShowHide Related Items >><<
W Wayfair
$280.50 /

-7.09 (-2.47%)

TRI Thomson Reuters
$70.45 /

+0.09 (+0.13%)

TEVA Teva
$12.07 /

-0.12 (-0.98%)

SRE Sempra Energy
$124.11 /

+0.05 (+0.04%)

REGN Regeneron
$641.43 /

-3.9 (-0.60%)

MRNA Moderna
$77.69 /

-0.29 (-0.37%)

HZNP Horizon Therapeutics
$61.40 /

-1.68 (-2.66%)

HUM Humana
$391.52 /

-3.36 (-0.85%)

EVRG Evergy
$56.21 /

-6.52 (-10.39%)

CVX Chevron
$86.07 /

+1.255 (+1.48%)

CRL Charles River
$204.19 /

-3.28 (-1.58%)

ABC AmerisourceBergen
$104.65 /

+0.15 (+0.14%)

CVX Chevron
$86.07 /

+1.255 (+1.48%)

08/04/20 Truist
Noble Energy downgraded to Hold from Buy at Truist
08/03/20 Stifel
Noble Energy downgraded to Hold from Buy at Stifel
07/23/20 Truist
SunTrust starts Chevron with Buy rating, $120 price target
07/23/20 Truist
Chevron initiated with a Buy at SunTrust
REGN Regeneron
$641.43 /

-3.9 (-0.60%)

08/04/20 Morgan Stanley
Regeneron preclinical antibody cocktail data 'encouraging,' says Morgan Stanley
07/20/20 Credit Suisse
Regeneron price target raised to $716 from $700 at Credit Suisse
07/09/20
Fly Intel: Top five analyst upgrades
07/08/20 Truist
Regeneron upgraded to Buy at SunTrust on Eylea resilience and pipeline
HUM Humana
$391.52 /

-3.36 (-0.85%)

07/27/20 BofA
Accolade initiated with a Buy at BofA
07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
07/01/20 SVB Leerink
Humana reinstated with an Outperform at SVB Leerink
SRE Sempra Energy
$124.11 /

+0.05 (+0.04%)

07/21/20 KeyBanc
KeyBanc upgrades Sempra Energy to Overweight with $141 target
07/21/20 KeyBanc
KeyBanc downgrades DTE Energy, prefers Sempra for cyclical exposure
07/21/20 KeyBanc
Sempra Energy upgraded to Overweight from Sector Weight at KeyBanc
06/15/20 Seaport Global
Seaport Global starts Sempra Energy at Buy with $142 price target
TRI Thomson Reuters
$70.45 /

+0.09 (+0.13%)

05/06/20
Fly Intel: Top five analyst downgrades
05/06/20
Fly Intel: Top five analyst upgrades
05/06/20 TD Securities
TD downgrades Thomson Reuters on valuation following BMO upgrade
05/06/20 TD Securities
Thomson Reuters downgraded to Hold from Buy at TD Securities
MRNA Moderna
$77.69 /

-0.29 (-0.37%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
07/27/20 BMO Capital
Moderna price target lowered to $94 from $112 at BMO Capital
W Wayfair
$280.50 /

-7.09 (-2.47%)

07/29/20 Credit Suisse
Wayfair price target raised to $260 from $198 at Credit Suisse
07/27/20 Wells Fargo
Wayfair price target raised to $225 from $215 at Wells Fargo
07/24/20 Piper Sandler
Wayfair price target raised to $275 from $225 at Piper Sandler
07/20/20 Goldman Sachs
Wayfair price target raised to $260 from $220 at Goldman Sachs
ABC AmerisourceBergen
$104.65 /

+0.15 (+0.14%)

06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
06/15/20 Morgan Stanley
AmerisourceBergen upgraded to Overweight from Equal Weight at Morgan Stanley
05/22/20 Wolfe Research
McKesson upgraded to Outperform from Peer Perform at Wolfe Research
05/18/20 Argus
Argus sees long term growth opportunities for AmerisourceBergen
EVRG Evergy
$56.21 /

-6.52 (-10.39%)

08/03/20 Wolfe Research
Evergy downgraded to Peer Perform from Outperform at Wolfe Research
07/06/20 Wells Fargo
Evergy price target raised to $66 from $60 at Wells Fargo
06/03/20 Evercore ISI
Evergy upgraded to Outperform from In Line at Evercore ISI
03/03/20 BofA
Evergy upgraded to Buy from Underperform at BofA
TEVA Teva
$12.07 /

-0.12 (-0.98%)

07/27/20 Goldman Sachs
Teva initiated with a Neutral at Goldman Sachs
07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
HZNP Horizon Therapeutics
$61.40 /

-1.68 (-2.66%)

07/31/20 Stifel
Horizon Therapeutics price target raised to $85 from $60 at Stifel
07/31/20 Morgan Stanley
Horizon Therapeutics price target raised to $70 from $50 at Morgan Stanley
07/22/20 Piper Sandler
Horizon Therapeutics price target raised to $90 from $61 at Piper Sandler
07/16/20 Guggenheim
Horizon Therapeutics price target raised to $64 from $50 at Guggenheim
CRL Charles River
$204.19 /

-3.28 (-1.58%)

07/21/20 UBS
Charles River price target raised to $236 from $200 at UBS
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
05/26/20 Argus
Charles River price target raised to $190 from $150 at Argus
W Wayfair
$280.50 /

-7.09 (-2.47%)

TRI Thomson Reuters
$70.45 /

+0.09 (+0.13%)

TEVA Teva
$12.07 /

-0.12 (-0.98%)

SRE Sempra Energy
$124.11 /

+0.05 (+0.04%)

REGN Regeneron
$641.43 /

-3.9 (-0.60%)

MRNA Moderna
$77.69 /

-0.29 (-0.37%)

HZNP Horizon Therapeutics
$61.40 /

-1.68 (-2.66%)

HUM Humana
$391.52 /

-3.36 (-0.85%)

EVRG Evergy
$56.21 /

-6.52 (-10.39%)

CVX Chevron
$86.07 /

+1.255 (+1.48%)

CRL Charles River
$204.19 /

-3.28 (-1.58%)

ABC AmerisourceBergen
$104.65 /

+0.15 (+0.14%)

  • 27
    May
  • 19
    May
  • 12
    Feb
W Wayfair
$280.50 /

-7.09 (-2.47%)

TRI Thomson Reuters
$70.45 /

+0.09 (+0.13%)

TEVA Teva
$12.07 /

-0.12 (-0.98%)

REGN Regeneron
$641.43 /

-3.9 (-0.60%)

MRNA Moderna
$77.69 /

-0.29 (-0.37%)

HUM Humana
$391.52 /

-3.36 (-0.85%)

EVRG Evergy
$56.21 /

-6.52 (-10.39%)

CVX Chevron
$86.07 /

+1.255 (+1.48%)

ABC AmerisourceBergen
$104.65 /

+0.15 (+0.14%)

W Wayfair
$280.50 /

-7.09 (-2.47%)

TEVA Teva
$12.07 /

-0.12 (-0.98%)

REGN Regeneron
$641.43 /

-3.9 (-0.60%)

MRNA Moderna
$77.69 /

-0.29 (-0.37%)

HUM Humana
$391.52 /

-3.36 (-0.85%)

CVX Chevron
$86.07 /

+1.255 (+1.48%)

ABC AmerisourceBergen
$104.65 /

+0.15 (+0.14%)

W Wayfair
$280.50 /

-7.09 (-2.47%)

TEVA Teva
$12.07 /

-0.12 (-0.98%)

REGN Regeneron
$641.43 /

-3.9 (-0.60%)

MRNA Moderna
$77.69 /

-0.29 (-0.37%)

HUM Humana
$391.52 /

-3.36 (-0.85%)

CVX Chevron
$86.07 /

+1.255 (+1.48%)

ABC AmerisourceBergen
$104.65 /

+0.15 (+0.14%)

Conference/Events
IBM to hold a virtual conference » 09:33
08/04/20
08/04
09:33
08/04/20
09:33
IBM

IBM

$124.29 /

+1.33 (+1.08%)

IBM Integration Technical…

IBM Integration Technical Virtual Conference 2020 will be held on August 4-6. Webcast Link

ShowHide Related Items >><<
IBM IBM
$124.29 /

+1.33 (+1.08%)

IBM IBM
$124.29 /

+1.33 (+1.08%)

07/22/20 Argus
IBM upgraded to Buy from Hold at Argus
07/22/20 Argus
IBM upgraded to Buy from Hold at Argus
07/21/20 Wells Fargo
IBM price target raised to $130 from $120 at Wells Fargo
07/21/20 Morgan Stanley
IBM price target raised to $128 from $111 at Morgan Stanley
IBM IBM
$124.29 /

+1.33 (+1.08%)

IBM IBM
$124.29 /

+1.33 (+1.08%)

IBM IBM
$124.29 /

+1.33 (+1.08%)

IBM IBM
$124.29 /

+1.33 (+1.08%)

Monday
Hot Stocks
MongoDB appoints Harsha Jalihal as Chief People Officer » 09:07
08/03/20
08/03
09:07
08/03/20
09:07
MDB

MongoDB

$228.84 /

+0.28 (+0.12%)

MongoDB appointed Harsha…

MongoDB appointed Harsha Jalihal as Chief People Officer. Most recently, Jalihal was Vice President of HR at Unilever. Jalihal was also on a part-time secondment to the World Economic Forum. Prior to that, she worked at Cognizant.

ShowHide Related Items >><<
MDB MongoDB
$228.84 /

+0.28 (+0.12%)

MDB MongoDB
$228.84 /

+0.28 (+0.12%)

06/24/20 Goldman Sachs
MongoDB price target raised to $215 from $169 at Goldman Sachs
06/05/20 DA Davidson
MongoDB price target raised to $215 from $105 at DA Davidson
06/05/20 Monness Crespi
MongoDB downgraded to Neutral on 'stretched' valuation at Monness Crespi
06/05/20 Monness Crespi
MongoDB downgraded to Neutral from Buy at Monness Crespi
MDB MongoDB
$228.84 /

+0.28 (+0.12%)

MDB MongoDB
$228.84 /

+0.28 (+0.12%)

MDB MongoDB
$228.84 /

+0.28 (+0.12%)

MDB MongoDB
$228.84 /

+0.28 (+0.12%)

Over a week ago
Hot Stocks
Humana announces $100M investment in telehealth start-up Heal » 08:36
07/29/20
07/29
08:36
07/29/20
08:36
HUM

Humana

$386.53 /

-4.74 (-1.21%)

Humana and Heal, a…

Humana and Heal, a company engaged in transforming healthcare through in-home, comprehensive primary care, announced a broad strategic partnership including a $100M investment from Humana, bringing primary care to the home through house calls and one-touch telemedicine. Under the terms of the partnership, Humana and Heal will expand its current footprint to offer value-based, primary care via virtual and in-home encounters to new geographical markets such as Chicago, Charlotte, Houston and others. These new markets are part of Humana's Bold Goal, which is focused on addressing the needs of the whole person by co-creating solutions to address social determinants and the health-related social needs for our members and communities. "The partnership with Heal is part of Humana's efforts to build a broader set of offerings across the spectrum of home based care, with high quality, value-based primary care being a key foundational element," said Susan Diamond, Humana's Segment President, Home Business, who is joining Heal's Board of Directors as part of the collaboration. "We continue to see high levels of customer satisfaction and improved health outcomes when care is delivered in the home. Our goal is to make the healthcare experience easier, more personalized and caring for the people we serve-and is the hallmark of how Humana delivers human care."

ShowHide Related Items >><<
HUM Humana
$386.53 /

-4.74 (-1.21%)

HUM Humana
$386.53 /

-4.74 (-1.21%)

07/27/20 BofA
Accolade initiated with a Buy at BofA
07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
07/01/20 SVB Leerink
Humana reinstated with an Outperform at SVB Leerink
HUM Humana
$386.53 /

-4.74 (-1.21%)

HUM Humana
$386.53 /

-4.74 (-1.21%)

HUM Humana
$386.53 /

-4.74 (-1.21%)

HUM Humana
$386.53 /

-4.74 (-1.21%)

Hot Stocks
IBM board approves regular quarterly cash dividend of $1.63 per share » 10:52
07/28/20
07/28
10:52
07/28/20
10:52
IBM

IBM

$125.47 /

-0.75 (-0.59%)

IBM announced that its…

IBM announced that its board of directors declared a regular quarterly cash dividend of $1.63 per common share, payable September 10 to stockholders of record August 10.

ShowHide Related Items >><<
IBM IBM
$125.47 /

-0.75 (-0.59%)

IBM IBM
$125.47 /

-0.75 (-0.59%)

07/22/20 Argus
IBM upgraded to Buy from Hold at Argus
07/22/20 Argus
IBM upgraded to Buy from Hold at Argus
07/21/20 Wells Fargo
IBM price target raised to $130 from $120 at Wells Fargo
07/21/20 Morgan Stanley
IBM price target raised to $128 from $111 at Morgan Stanley
IBM IBM
$125.47 /

-0.75 (-0.59%)

IBM IBM
$125.47 /

-0.75 (-0.59%)

IBM IBM
$125.47 /

-0.75 (-0.59%)

IBM IBM
$125.47 /

-0.75 (-0.59%)

Initiation
Accolade initiated with a Buy at BofA » 06:19
07/27/20
07/27
06:19
07/27/20
06:19
ACCD

Accolade

$32.97 /

+0.63 (+1.95%)

, HUM

Humana

$391.95 /

-5.89 (-1.48%)

BofA analyst Michael…

BofA analyst Michael Cherny initiated coverage of Accolade (ACCD) with a Buy rating and $37 price target. The analyst is positive on the company's differentiated approach towards the coordination and navigation of health benefits as well as its partnership with Humana (HUM) and the recent pilot with the Department of Defense, allowing for opportunities to broaden its reach over time.

ShowHide Related Items >><<
HUM Humana
$391.95 /

-5.89 (-1.48%)

ACCD Accolade
$32.97 /

+0.63 (+1.95%)

07/27/20 Morgan Stanley
Accolade initiated with an Overweight at Morgan Stanley
07/27/20 BofA
Accolade initiated with a Buy at BofA
07/27/20 Credit Suisse
Accolade initiated with a Neutral at Credit Suisse
07/27/20 Goldman Sachs
Accolade initiated with a Buy at Goldman Sachs
HUM Humana
$391.95 /

-5.89 (-1.48%)

07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
07/01/20 SVB Leerink
Humana reinstated with an Outperform at SVB Leerink
06/18/20 Deutsche Bank
Humana price target lowered to $397 from $421 at Deutsche Bank
HUM Humana
$391.95 /

-5.89 (-1.48%)

  • 02
    Jul
HUM Humana
$391.95 /

-5.89 (-1.48%)

HUM Humana
$391.95 /

-5.89 (-1.48%)

ACCD Accolade
$32.97 /

+0.63 (+1.95%)

HUM Humana
$391.95 /

-5.89 (-1.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.